Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

Related Citations for PubMed (Select 18773084)

1.

Multiple advantageous amino acid variants in the NAT2 gene in human populations.

Luca F, Bubba G, Basile M, Brdicka R, Michalodimitrakis E, Rickards O, Vershubsky G, Quintana-Murci L, Kozlov AI, Novelletto A.

PLoS One. 2008 Sep 5;3(9):e3136. doi: 10.1371/journal.pone.0003136.

2.

Arylamine N-acetyltransferase 2 (NAT2) genetic diversity and traditional subsistence: a worldwide population survey.

Sabbagh A, Darlu P, Crouau-Roy B, Poloni ES.

PLoS One. 2011 Apr 6;6(4):e18507. doi: 10.1371/journal.pone.0018507.

3.

Population genetic diversity of the NAT2 gene supports a role of acetylation in human adaptation to farming in Central Asia.

Magalon H, Patin E, Austerlitz F, Hegay T, Aldashev A, Quintana-Murci L, Heyer E.

Eur J Hum Genet. 2008 Feb;16(2):243-51. Epub 2007 Nov 28.

4.

Analysis of nucleotide diversity of NAT2 coding region reveals homogeneity across Native American populations and high intra-population diversity.

Fuselli S, Gilman RH, Chanock SJ, Bonatto SL, De Stefano G, Evans CA, Labuda D, Luiselli D, Salzano FM, Soto G, Vallejo G, Sajantila A, Pettener D, Tarazona-Santos E.

Pharmacogenomics J. 2007 Apr;7(2):144-52. Epub 2006 Jul 18.

5.

Deciphering the ancient and complex evolutionary history of human arylamine N-acetyltransferase genes.

Patin E, Barreiro LB, Sabeti PC, Austerlitz F, Luca F, Sajantila A, Behar DM, Semino O, Sakuntabhai A, Guiso N, Gicquel B, McElreavey K, Harding RM, Heyer E, Quintana-Murci L.

Am J Hum Genet. 2006 Mar;78(3):423-36. Epub 2006 Jan 13.

6.

Worldwide distribution of NAT2 diversity: implications for NAT2 evolutionary history.

Sabbagh A, Langaney A, Darlu P, Gérard N, Krishnamoorthy R, Poloni ES.

BMC Genet. 2008 Feb 27;9:21. doi: 10.1186/1471-2156-9-21.

7.

N-Acetyltransferase-2 (NAT2) gene polymorphisms and enzyme activity in Serbs: unprecedented high prevalence of rapid acetylators in a White population.

Djordjevic N, Carrillo JA, Ueda N, Gervasini G, Fukasawa T, Suda A, Jankovic S, Aklillu E.

J Clin Pharmacol. 2011 Jul;51(7):994-1003. doi: 10.1177/0091270010377630. Epub 2010 Aug 27.

PMID:
20801937
8.

Arylamine N-acetyltransferase-2 genotypes in the Thai population.

Kukongviriyapan V, Prawan A, Tassaneyakul W, Aiemsa-Ard J, Warasiha B.

Br J Clin Pharmacol. 2003 Mar;55(3):278-81.

9.

Polymorphic N-acetyltransferase (NAT2) genotyping of Emiratis.

Woolhouse NM, Qureshi MM, Bastaki SM, Patel M, Abdulrazzaq Y, Bayoumi RA.

Pharmacogenetics. 1997 Feb;7(1):73-82.

PMID:
9110365
10.

Genetic profile of the arylamine N-acetyltransferase 2 coding gene among individuals from two different regions of Brazil.

Teixeira RL, Miranda AB, Pacheco AG, Lopes MQ, Fonseca-Costa J, Rabahi MF, Melo HM, Kritski AL, Mello FC, Suffys PN, Santos AR.

Mutat Res. 2007 Nov 1;624(1-2):31-40. Epub 2007 Apr 19.

PMID:
17509624
11.

Sub-Saharan African coding sequence variation and haplotype diversity at the NAT2 gene.

Patin E, Harmant C, Kidd KK, Kidd J, Froment A, Mehdi SQ, Sica L, Heyer E, Quintana-Murci L.

Hum Mutat. 2006 Jul;27(7):720.

PMID:
16786516
12.

Genotype and allele frequencies of N-acetyltransferase 2 and glutathione S-transferase in the Iranian population.

Torkaman-Boutorabi A, Hoormand M, Naghdi N, Bakhshayesh M, Milanian I.

Clin Exp Pharmacol Physiol. 2007 Nov;34(11):1207-11.

PMID:
17880378
13.

N-acetyltransferase polymorphism among northern Sudanese.

Al-Yahyaee S, Gaffar U, Al-Ameri MM, Qureshi M, Zadjali F, Ali BH, Bayoumi R.

Hum Biol. 2007 Aug;79(4):445-52.

PMID:
18075007
14.

Meta-analysis of phenotype and genotype of NAT2 deficiency in Chinese populations.

Xie HG, Xu ZH, Ou-Yang DS, Shu Y, Yang DL, Wang JS, Yan XD, Huang SL, Wang W, Zhou HH.

Pharmacogenetics. 1997 Dec;7(6):503-14.

PMID:
9429236
15.

Distribution and concordance of N-acetyltransferase genotype and phenotype in an American population.

Gross M, Kruisselbrink T, Anderson K, Lang N, McGovern P, Delongchamp R, Kadlubar F.

Cancer Epidemiol Biomarkers Prev. 1999 Aug;8(8):683-92.

16.

Identification and prevalence study of 17 allelic variants of the human NAT2 gene in a white population.

Agúndez JA, Olivera M, Martínez C, Ladero JM, Benítez J.

Pharmacogenetics. 1996 Oct;6(5):423-8.

PMID:
8946474
17.

Polymorphisms of promoter and coding regions of the arylamine N-acetyltransferase 2 (NAT2) gene in the Indonesian population: proposal for a new nomenclature.

Yuliwulandari R, Sachrowardi Q, Nishida N, Takasu M, Batubara L, Susmiarsih TP, Rochani JT, Wikaningrum R, Miyashita R, Miyagawa T, Sofro AS, Tokunaga K.

J Hum Genet. 2008;53(3):201-9. Epub 2007 Dec 27.

PMID:
18160997
18.

N-acetyltransferase 2 acetylation polymorphism: prevalence of slow acetylators does not differ between atopic dermatitis patients and healthy subjects.

Brocvielle H, Muret P, Goydadin AC, Boone P, Broly F, Kantelip JP, Humbert P.

Skin Pharmacol Appl Skin Physiol. 2003 Nov-Dec;16(6):386-92.

PMID:
14528063
19.

Analysis of six SNPs of NAT2 in Ngawbe and Embera Amerindians of Panama and determination of the Embera acetylation phenotype using caffeine.

Jorge-Nebert LF, Eichelbaum M, Griese EU, Inaba T, Arias TD.

Pharmacogenetics. 2002 Jan;12(1):39-48.

PMID:
11773863
20.

Genotyping of the polymorphic N-acetyltransferase (NAT2*) gene locus in two native African populations.

Deloménie C, Sica L, Grant DM, Krishnamoorthy R, Dupret JM.

Pharmacogenetics. 1996 Apr;6(2):177-85.

PMID:
9156695
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk